Burkitt’s lymphoma of the skull calotte: a case report

Introduction: Burkitt’s lymphoma is a non- Hodgkin B-cell lymphoma whose cranial location is extremely rare. Clinical case: The case of a 35-year-old Peruvian man with a progressive parietal left cranial tumor is described. A biopsy with immunohistochemistry was performed for the diagnostic confirma...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerron-Vela, Carmen Rosa, Araujo-Banchon, William J
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2020
Materias:
lymphoma, Non-Hodgkin
skull
Peru
linfoma no Hodgkin
cráneo
Perú
linfoma não Hodgkin
crânio
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/26764
Aporte de:
Revista de la Facultad de Ciencias Médicas de Córdoba de Universidad Nacional de Córdoba
id I10-R327-article-26764
record_format ojs
spelling I10-R327-article-267642024-08-27T18:27:11Z Burkitt’s lymphoma of the skull calotte: a case report Linfoma de Burkitt de la calota craneana: a propósito de un caso Linfoma de Burkitt da calota craniana: relato de caso Cerron-Vela, Carmen Rosa Araujo-Banchon, William J lymphoma, Non-Hodgkin skull Peru linfoma no Hodgkin cráneo Perú linfoma não Hodgkin crânio Peru Introduction: Burkitt’s lymphoma is a non- Hodgkin B-cell lymphoma whose cranial location is extremely rare. Clinical case: The case of a 35-year-old Peruvian man with a progressive parietal left cranial tumor is described. A biopsy with immunohistochemistry was performed for the diagnostic confirmation of Burkitt’s lymphoma. First-line outpatient treatment with CODOX-M/IVAC was initiated, however, he stopped attending his treatment for 2 months. He returns, he is shown progression of the disease and is treated with rituximab, ifosfamide carboplatin and etoposide. Does not respond satisfactorily and dies. Conclusions: Burkitt’s lymphoma is a very aggressive tumor that, if not treated in a timely manner, has high mortality, as happened with the patient in the case. Introducción: El linfoma de Burkitt es un linfoma no Hodgkin de células B cuya ubicación craneal es extremadamente rara. Caso clínico: Se describe el caso de un hombre peruano de 35 años con una tumoración craneal parietal izquierda de crecimiento progresivo. Para la confirmación diagnóstica de linfoma de Burkitt se realizó una biopsia con inmunohistoquímica. Se inició tratamiento ambulatorio de primera línea con CODOX-M/IVAC, sin embargo, deja de acudir a su tratamiento por 2 meses. Retorna, se le evidencia progresión de la enfermedad y se le trata con rituximab, ifosfamida carboplatino y etopósido. No responde de forma satisfactoria y fallece. Conclusiones: El Linfoma de Burkitt es un tumor muy agresivo que si no es tratado oportunamente presenta alta mortalidad, tal como ocurrió con el paciente del caso. Introdução: O linfoma de Burkitt é um linfoma de células B não-Hodgkin cuja localização craniana é extremamente rara. Caso clínico: É descrito o caso de um homem peruano de 35 anos com um tumor craniano esquerdo progressivo parietal. Uma biópsia com imuno-histoquímica foi realizada para confirmação diagnóstica do linfoma de Burkitt. O tratamento ambulatorial de primeira linha com CODOX-M/IVAC foi iniciado; no entanto, ele parou de participar do tratamento por 2 meses. Ele retorna, mostra progressão da doença e é tratado com rituximabe, ifosfamida carboplatina e etoposídeo. Não responde satisfatoriamente e morre. Conclusões: O linfoma de Burkitt é um tumor muito agressivo que, se não tratado em tempo hábil, apresenta alta mortalidade, como ocorreu com o paciente no caso. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2020-04-14 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion text/html application/pdf https://revistas.unc.edu.ar/index.php/med/article/view/26764 10.31053/1853.0605.v77.n2.26764 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 77 No. 2 (2020); 106-109 Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 77 Núm. 2 (2020); 106-109 Revista da Faculdade de Ciências Médicas de Córdoba; v. 77 n. 2 (2020); 106-109 1853-0605 0014-6722 10.31053/1853.0605.v77.n2 spa https://revistas.unc.edu.ar/index.php/med/article/view/26764/29486 https://revistas.unc.edu.ar/index.php/med/article/view/26764/29871 Derechos de autor 2020 Universidad Nacional de Córdoba https://creativecommons.org/licenses/by-nc/4.0
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-327
container_title_str Revista de la Facultad de Ciencias Médicas de Córdoba
language Español
format Artículo revista
topic lymphoma, Non-Hodgkin
skull
Peru
linfoma no Hodgkin
cráneo
Perú
linfoma não Hodgkin
crânio
Peru
spellingShingle lymphoma, Non-Hodgkin
skull
Peru
linfoma no Hodgkin
cráneo
Perú
linfoma não Hodgkin
crânio
Peru
Cerron-Vela, Carmen Rosa
Araujo-Banchon, William J
Burkitt’s lymphoma of the skull calotte: a case report
topic_facet lymphoma, Non-Hodgkin
skull
Peru
linfoma no Hodgkin
cráneo
Perú
linfoma não Hodgkin
crânio
Peru
author Cerron-Vela, Carmen Rosa
Araujo-Banchon, William J
author_facet Cerron-Vela, Carmen Rosa
Araujo-Banchon, William J
author_sort Cerron-Vela, Carmen Rosa
title Burkitt’s lymphoma of the skull calotte: a case report
title_short Burkitt’s lymphoma of the skull calotte: a case report
title_full Burkitt’s lymphoma of the skull calotte: a case report
title_fullStr Burkitt’s lymphoma of the skull calotte: a case report
title_full_unstemmed Burkitt’s lymphoma of the skull calotte: a case report
title_sort burkitt’s lymphoma of the skull calotte: a case report
description Introduction: Burkitt’s lymphoma is a non- Hodgkin B-cell lymphoma whose cranial location is extremely rare. Clinical case: The case of a 35-year-old Peruvian man with a progressive parietal left cranial tumor is described. A biopsy with immunohistochemistry was performed for the diagnostic confirmation of Burkitt’s lymphoma. First-line outpatient treatment with CODOX-M/IVAC was initiated, however, he stopped attending his treatment for 2 months. He returns, he is shown progression of the disease and is treated with rituximab, ifosfamide carboplatin and etoposide. Does not respond satisfactorily and dies. Conclusions: Burkitt’s lymphoma is a very aggressive tumor that, if not treated in a timely manner, has high mortality, as happened with the patient in the case.
publisher Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2020
url https://revistas.unc.edu.ar/index.php/med/article/view/26764
work_keys_str_mv AT cerronvelacarmenrosa burkittslymphomaoftheskullcalotteacasereport
AT araujobanchonwilliamj burkittslymphomaoftheskullcalotteacasereport
AT cerronvelacarmenrosa linfomadeburkittdelacalotacraneanaapropositodeuncaso
AT araujobanchonwilliamj linfomadeburkittdelacalotacraneanaapropositodeuncaso
AT cerronvelacarmenrosa linfomadeburkittdacalotacranianarelatodecaso
AT araujobanchonwilliamj linfomadeburkittdacalotacranianarelatodecaso
first_indexed 2024-09-03T21:01:36Z
last_indexed 2024-09-03T21:01:36Z
_version_ 1809210195331514368

Ejemplares similares